论文部分内容阅读
喘息性支气管炎是一组临床综合征,泛指一组有喘息表现的婴幼儿急性支气管感染,多见于1岁～3岁的婴幼儿,常继发于上呼吸道感染之后,肺实质很少受累。其中部分患儿可发展为支气管哮喘。我院从2005年1月开始引进采用硫酸沙丁胺醇雾化溶液(万托林)联合吸入性异丙托溴胺溶液(爱全乐),通过压缩雾化吸入机雾化吸入治疗喘息性支气管炎取得了满意的效果。现报告如下。
Asthmatic bronchitis is a group of clinical syndromes, refers to a group of children with wheezing acute bronchial infection, more common in children aged 1 to 3 years old, often secondary to upper respiratory tract infection, the lung parenchyma rarely affected . Some of these children can develop bronchial asthma. Our hospital from January 2005 introduced the use of salbutamol sulfate atomization solution (Wan Tolrine) combined with inhalation of ipratropium bromide solution (AstraZeneca) by atomizing inhalation inhalation inhalation therapy for asthmatic bronchitis Satisfied with the results. The report is as follows.